Skip to content

Clinical trials

Phase 1 Cardiovascular Diseases trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Cardiovascular Diseases Phase: Phase 1 Country / region: United States Clear all

94 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20045
20052
20061
20074
20084
20099
20102
20113
20121
20134
20146
20154
20164
20173
20189
20191
20204
20214
20225
20235
20246
20251
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed72
Recruiting9
Unknown status5
Terminated3
Withdrawn2
Not yet recruiting1
Enrolling by invitation1
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Heart, Lung, and Blood Institute (NHLBI)6
Amgen5
The University of Texas at Arlington5
AstraZeneca4
Penn State University3
University of California, Davis3
Bristol-Myers Squibb2
GlaxoSmithKline2
Northwell Health2
Northwestern University2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Cardiovascular Diseases94
Heart Failure9
Hypertension9
Obesity9
Vascular Diseases9
Heart Diseases8
Atherosclerosis7
Diabetes Mellitus, Type 25
Peripheral Arterial Disease5
Diabetes Mellitus4

Trials

Showing 1 to 25 of 94. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.